Breast Cancer Society of Canada
Breast cancer is the most common cancer among Canadian
women (excluding non-melanoma skin cancers). It is the 2nd
leading cause of death from cancer in Canadian women.
Breast cancer can also occur in men, but it is not common.
In 2017, an estimated:
26,300 women were diagnosed with breast cancer. This represents 25% of all new cancer cases
in in 2017.
5,000 women died from breast cancer. This represents 13% of all cancer deaths in women in 2017.
On average, 72 Canadian women were diagnosed with breast cancer every day.
On average, 14 Canadian women died from breast cancer every day.
230 men were diagnosed with breast cancer and 60 died from breast cancer.
Prostate Cancer Canada
Prostate Cancer is the most common cancer in men; 1 in 7 Canadian
men will be diagnosed with prostate cancer in their lifetime.
21,300 expected new cases in 2017.
4,100 estimated deaths in 2017.
Early detection saves lives. When detected early, the survival
rate for prostate cancer is over 90%.
Men and their families are encouraged to initiate a shared decision-making process with their
doctors regarding prostate cancer.
In agreement with prostate cancer experts, Prostate Cancer Canada advocates for a “smart screening” approachto early detection which takes men’s personal risk into account; such as age, family history and ethnicity. This involves getting a Prostate Specific Antigen (PSA) test at age 40 to establish a baseline number which is then incorporated into the man’s risk profile to determine when the next PSA test needs to occur. The PSA test is a simple blood test, taken from your arm, which measures the amount of prostate antigen in your blood. Men should get a PSA test in their 40’s to establish their baseline. Men at high risk for prostate cancer should talk to their doctor before age 40 about prostate cancer
Leukemia & Lymphoma Society of Canada
The Leukemia and Lymphoma Society of Canada (LLSC)
is Canada’s largest organization that funds life-saving
blood cancer research, and provides support services to
patients and their families.
The mission of the LLSC is: Cure leukemia, lymphoma,
Hodgkin’s disease and myeloma, and improve the
quality of life of patients and their families.
With over 137 types of blood cancer, approximately 138,100 people in Canada are
living with, or are in remission from a form of blood cancer.
This past year, LLSC increased its research commitment to $4.2 million and supported
35 research projects acrossCanada. LLSC is proud to be a strong community who has supported
over 27,000 patients and is lucky to have over 37,000 volunteers across Canada.